SCHEMBL14504656

SCHEMBL14504656

CCN(C)C(=O)c1cc(-c2ccc(OCCNC(=O)OC(C)(C)C)cc2)n(-c2ccc(OC)cc2)n1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MALT1 Q9UDY8 4/20 0.45
RPA1 P27694 5/20 0.45
CHRNA7 P36544 1/20 0.45
BCL2 P10415 2/20 0.43
MDM2 Q00987 2/20 0.43
MCL1 Q07820 2/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
MARS1 P56192 1/20 0.41
PTGS2 P35354 4/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
ALOX5 P09917 1/20 0.40
PTGS1 P23219 1/20 0.40
FABP3 P05413 1/20 0.39
FABP4 P15090 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14504659 0.91 MALT1 (0.46) MALT1RPA1CHRNA7BCL2MDM2
SCHEMBL14504706 0.88 CHRNA7 (0.49) MALT1RPA1CHRNA7BCL2MDM2
SCHEMBL14504739 0.88 RPA1 (0.60) MALT1RPA1CHRNA7BCL2MDM2
SCHEMBL14504993 0.87 MALT1 (0.48) MALT1RPA1CHRNA7BCL2MDM2
SCHEMBL5152086 0.86 FAAH (0.51) MALT1RPA1CHRNA7BCL2MDM2
SCHEMBL5148904 0.86 MALT1 (0.48) MALT1RPA1CHRNA7BCL2MDM2
SCHEMBL14505053 0.85 MALT1 (0.47) MALT1RPA1CHRNA7BCL2MDM2
SCHEMBL14608131 0.85 MALT1 (0.52) MALT1RPA1CHRNA7BCL2MDM2
SCHEMBL5150536 0.85 CA1 (0.45) MALT1RPA1CHRNA7CA12CA1
SCHEMBL14504643 0.85 RPA1 (0.54) MALT1RPA1CHRNA7BCL2MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112037-A1 Pyrazole Derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2007-05-17 US disclosed
US-20070112037-A1 Pyrazole Derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2007-05-17 US disclosed
US-7183306-B2 Pyrazole derivatives ASTELLAS PHARMA INC. (JP) 2007-02-27 US disclosed
US-7183306-B2 Pyrazole derivatives ASTELLAS PHARMA INC. (JP) 2007-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112037-A1 Pyrazole Derivatives CYP11B2, CYP11B1, CYP3A43 MALT1 1227/4885RPA1 2143/4885CHRNA7 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.